BERKELEY, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company's participation in the following investor conferences:
- Citi 18th Annual BioPharma Conference, Boston, MA
September 6, 2023 - Wells Fargo Healthcare Conference, Boston, MA
September 7, 2023, 8:00 am EDT - Morgan Stanley 21st Annual Global Healthcare Conference, New York, NY
September 11, 2023 - Jefferies Cell & Genetic Medicine Summit, New York, NY
September 26-27, 2023
For more information and links to available webcasts, visit the Events page on Caribou's website. Webcasts will be ...